Common thyroid hormone may help prevent brain tumor relapse in children, says study
Researchers at Fox Chase Cancer Center have discovered that the thyroid hormone triiodothyronine (T3) may help prevent the recurrence of medulloblastoma in children. By promoting cell differentiation, the hormone encourages tumor cells to mature and stop dividing, potentially improving outcomes when combined with chemotherapy.
Why it matters
This finding offers a promising, less toxic approach to treating aggressive pediatric brain tumors, which currently have a high rate of recurrence.
edited by Gaby Clark , reviewed by Andrew Zinin
The article reports on scientific research findings without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in